Gene · 7083
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated thymidine kinase 1 expression at baseline predicts poor prognosis in breast cancer patients. | Front Oncol | 2026 | 41695368 | PubTator, text mining | PubMed |
| Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors. | Breast Cancer Res Treat | 2026 | 41670750 | PubTator, text mining | PubMed |
| Mining in Endometrial Cancer Based on the TCGA Database and Constructing Prognostic Models. | J Vis Exp | 2026 | 41628059 | PubTator, text mining | PubMed |
| Acetylated Pyrimidine Metabolism Genes as Prognostic Markers and Their Influence on Immune Profiles in Lung Adenocarcinoma. | Hum Mutat | 2026 | 41584726 | PubTator, text mining | PubMed |
| CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction. | Nat Commun | 2026 | 41571637 | PubTator, text mining | PubMed |
| A novel APE1-assisted cycling amplification for rapid and ultrasensitive SERS detection of TK1 mRNA in human serum. | Anal Methods | 2026 | 41542754 | PubTator, text mining | PubMed |
| High Thymidine Kinase 1 Activity Linked to Poor Breast Cancer Survival: A Systematic Review and Meta-Analysis. | Clin Breast Cancer | 2026 | 41206233 | PubTator, text mining | PubMed |
| Thymidine kinase 1 (TK1) as a proteomic biomarker in cancer. | Clin Chim Acta | 2026 | 41183606 | PubTator, text mining | PubMed |
| Rank Aggregation Methods and Tools in Genomic Data Analysis. | Curr Genomics | 2025 | 41450822 | PubTator, text mining | PubMed |
| Discovery of Essential Genes as Possible Targets for Prostate Cancer Drug Development. | Int J Genomics | 2025 | 41446353 | PubTator, text mining | PubMed |
| A Comprehensive multi-network analysis of ceRNAs and transcription factors for papillary thyroid carcinoma diagnosis and prognosis. | Sci Rep | 2025 | 41271882 | PubTator, text mining | PubMed |
| Multiplexed RNA imaging and in situ profiling in living cells. | Chem Sci | 2025 | 41210282 | PubTator, text mining | PubMed |
| Multiplex Aptamer-Guided DNA Nanosuppressors for Quantitative Modulation of Autophagy-Survivin Crosstalk and Imaging-Guided Apoptosis Induction. | Anal Chem | 2025 | 41144653 | PubTator, text mining | PubMed |
| Thymidine kinase 1 related to Prolif-like T cells promoted GBM through regulation of cell cycle and EMT signals: a comprehensive research based on multi-omics analysis and experimental validation. | Front Immunol | 2025 | 41080536 | PubTator, text mining | PubMed |
| In-silico identification of host-key-genes associated with dengue-virus-infections highlighting their pathogenetic mechanisms and therapeutic agents. | PLoS One | 2025 | 41056367 | PubTator, text mining | PubMed |
Combination of prostate cancer antigen 3 (PCA3), sarcosine, glypican-1 (GPC1), urokinase plasminogen activator receptor (uPAR), and thymidine kinase 1 (TK1), and T2WI and DWI radiomics model for distinguishing benign prostatic hyperplasia, prostate cancer, and prostatitis. | J Med Biochem | 2025 | 41054593 | PubTator, text mining | PubMed |
| High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS. | Nucleic Acids Res | 2025 | 41047139 | PubTator, text mining | PubMed |
| mcRigor: a statistical method to enhance the rigor of metacell partitioning in single-cell data analysis. | Nat Commun | 2025 | 41022768 | PubTator, text mining | PubMed |
Tumor microenvironment delineates differential responders to trastuzumab emtansine in HER2-positive metastatic breast cancer patients previously treated with pyrotinib: an exploratory biomarker analysis of a phase II study (NJMU-BC02). | Signal Transduct Target Ther | 2025 | 41016944 | PubTator, text mining | PubMed |
| Epitranscriptomic Regulation of Hepatitis B Virus by RNA 5-Methylcytosine: Functions, Mechanisms, and Therapeutic Potential. | Viruses | 2025 | 41012587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7083/papers?page=3